Retinal degenerative diseases may be inhibited with tetracyclines

MIAMI — Tetracyclines may inhibit the molecular pathways that contribute to retinal degenerative diseases, specifically retinitis pigmentosa and macular degeneration, a speaker said here.According to Elias Reichel, MD, the TOGA study, a phase 3 study evaluating treatment with Oracea (doxycycline, Galderma) in geographic atrophy, will compare doxycycline with placebo in reducing the rate of change in area of geographic atrophy.

Full Story →